Cancer chemotherapy and biotherapy principles and practice
Updated to include the newest drugs and those currently in development, Cancer Chemotherapy and Biotherapy, Fifth Edition is a comprehensive reference on the preclinical and clinical pharmacology of anticancer agents. Organized by drug class, the book provides the latest information on all drugs and...
Saved in:
Other Authors: | , |
---|---|
Format: | Book |
Language: | English |
Published: |
Philadelphia, Pennsylvania
Wolters Kluwer Health/Lippincott Williams & Wilkins
2011
|
Edition: | Fifth Edition |
Subjects: | |
Online Access: | Click Here to View Status and Holdings. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000nam a2200000#i 4501 | ||
---|---|---|---|
001 | wils-457830 | ||
005 | 201934161714 | ||
008 | 220526t20112011PAU a #001 deng D | ||
020 | # | # | |a 9781605474311 |q hardback |
020 | # | # | |a 1605474312 |q hardback |
040 | # | # | |a DNLM/DLC |d UiTM |e rda |
041 | 0 | # | |a English |
060 | 0 | 0 | |a QZ 267 |
090 | 0 | 0 | |a QZ267 |b C21515 2011 |
245 | 0 | 0 | |a Cancer chemotherapy and biotherapy |b principles and practice |c edited by Bruce A. Chabner, Dan L. Longo |
250 | # | # | |a Fifth Edition |
264 | # | 1 | |a Philadelphia, Pennsylvania |b Wolters Kluwer Health/Lippincott Williams & Wilkins |c 2011 |
264 | # | 4 | |c ©2011 |
300 | # | # | |a xv, 812 pages |b illustrations (some color) |c 29 cm |
336 | # | # | |a text |b txt |2 rdacontent |
337 | # | # | |a unmediated |b n |2 rdamedia |
338 | # | # | |a volume |b nc |2 rdacarrier |
504 | # | # | |a Includes bibliographical references and index |
520 | # | # | |a Updated to include the newest drugs and those currently in development, Cancer Chemotherapy and Biotherapy, Fifth Edition is a comprehensive reference on the preclinical and clinical pharmacology of anticancer agents. Organized by drug class, the book provides the latest information on all drugs and biological agents-their mechanisms of action, interactions with other agents, toxicities, side effects, and mechanisms of resistance. Chapters emphasize pharmacology and mechanisms of action at the molecular and cellular levels, followed by clinical activity and toxicity, both acute and delayed. The authors explain the rationale for use of drugs in specific schedules and combinations and offer guidelines for dose adjustment in particular situations. This edition's introduction includes timely information on general strategies for drug usage, the science of drug discovery and development, economic and regulatory aspects of cancer drug development, and principles of pharmacokinetics. Eight new chapters have been added and more than twenty have been significantly revised. A companion website includes the fully searchable text and an image bank |
650 | 1 | 2 | |a Neoplasms |x drug therapy |
650 | 2 | 2 | |a Antineoplastic Agents |x therapeutic use |
650 | 2 | 2 | |a Biological Products |x therapeutic use |
700 | 1 | # | |a Chabner, Bruce |d 1949- |e editor |q Dan Louis |
700 | 1 | # | |a Longo, Dan L. |d 1949- |e editor |q Dan Louis |
856 | 4 | 0 | |z Click Here to View Status and Holdings. |u https://opac.uitm.edu.my/opac/detailsPage/detailsHome.jsp?tid=457830 |
964 | # | # | |c BOK |d MD |
998 | # | # | |a 00250##a002.5.2||00250##b002.5.3||00255##a006.11||00260##a002.8.2||00260##b002.8.4||00260##c002.7.6||00264#1a006.11||00264#1b006.11||00300##a003.4.1||00300##b003.6.1||00300##c003.5.1||00500##a006.11||00502##a006.11||00520##a006.11||00520##b006.11||00538##a006.11||00546##a006.11||01700##a0011.2.2||01700##d0017.8||01700##q0017.8||00730##a006.2.2||00730##d006.4||00730##f006.10||00730##n006.2.2||00730##p006.2.2|| |